Bronchodilators: Racemic Epinephrine
Beta-agonist properties reverse bronchoconstriction,
while alpha-agonist properties cause vasoconstriction and reduce
oedema. Evidence support that it is superior to placebo for
short-term outcomes hospitalization within 24 hours but has no
effects on: inpatient clinical course, vital signs, LOS and readmissions.2
It is not currently recommended as it is not superior
to saline, therefore, should not be given